Eurogroup agrees term sheet on euro-area budgetary instrument and revised ESM treaty
Following the mandate received by EU leaders at the 14 December Euro Summit, the Eurogroup in inclusive format discussed and took decisions on deepening of the Economic and Monetary Union (EMU).
Mário Centeno, President of the Eurogroup recently said:
Our aim was to deliver on three key areas ahead of the Euro Summit: the budgetary instrument, the ESM Treaty and Banking Union. More work is needed, but we made real progress.
Ministers agreed on:
- a term sheet describing the main features of the budgetary instrument for competitiveness and convergence.
- a revised ESM treaty draft, covering issues such as the common backstop for bank resolution, the precautionary instruments as well as institutional aspects and the issue of cooperation between the ESM and the European Commission within and outside programmes.
Both documents, together with a cover letter from the President of the Eurogroup summarising all the main elements of the Eurogroup's discussion on the EMU reform, have been submitted to the President of the European Council, in preparation of the Euro Summit of 21 June.
- Letter by President Centeno to President Tusk on the deepening of the economic and monetary union
- Term sheet on the budgetary instrument for convergence and competitiveness (press release, 14 June 2019)
- Revised draft of the ESM treaty as agreed by Eurogroup
- Annexes to the revised draft of the ESM treaty
Eurogroup President Spokesperson
+32 2 281 24 63
+32 470 88 23 83
Latest News from
EC opens investigation into possible anti-competitive conduct of Amazon18/07/2019 15:25:00
The EC has opened a formal antitrust investigation to assess whether Amazon's use of sensitive data from independent retailers who sell on its marketplace is in breach of EU competition rules.
Turkish drilling activities in the Eastern Mediterranean16/07/2019 15:25:00
The Council adopted the following conclusions on the Turkish drilling activities in the Eastern Mediterranean.
Four new substances added to the Candidate List16/07/2019 13:43:00
The Candidate List of substances of very high concern (SVHCs) for authorisation now contains 201 substances.
Imports of hormone-free beef: EU-US agreement confirmed16/07/2019 11:43:00
The Council has adopted a decision on the signing of an agreement between the EU and the US on the allocation to the US of a share in the TRQ for high quality beef regarding the importation of beef from animals not treated with certain growth-promoting hormones.
EIOPA consults on the harmonisation of national insurance guarantee schemes15/07/2019 12:32:00
Tthe European Insurance and Occupational Pension Authority (EIOPA) has launched a consultation on its Advice on the harmonisation of national insurance guarantee schemes across the Member States of the European Union.
EU-U.S. trade talks: milestone reached in mutual recognition on pharmaceuticals12/07/2019 15:25:00
The EU and the USA have delivered on a significant element of the Joint Statement agreed by Presidents Juncker and Trump in July 2018. The positive transatlantic trade agenda established in the Joint Statement includes a commitment from both sides to reduce barriers and increase trade in a range of sectors, including pharmaceuticals.
Airbnb cooperates with EC and EU consumer authorities improving the way it presents offers12/07/2019 13:25:00
The EC has announced that, as a result of negotiations with Airbnb, the platform has improved and fully clarified the way it presents accommodation offers to consumers, which is now in line with the standards set in EU consumer law.
European Institute of Innovation and Technology: EC proposes strategy for 2021-202712/07/2019 11:33:00
The EC has proposed an update of the legal base of the European Institute of Innovation and Technology (EIT) as well as its new Strategic Innovation Agenda for 2021-2027.
EC approves GlaxoSmithKline's acquisition of Pfizer's Consumer Health Business with conditions11/07/2019 15:25:00
The EC has approved, under the EU Merger Regulation, the acquisition of Pfizer's Consumer Health Business by GlaxoSmithKline. The decision is conditional upon the global divestment of Pfizer's topical pain management business carried out under the ThermaCare brand.